Archer Daniels faces a challenging market and weakness in its Ag Services and Oilseeds unit.

NEW YORK, NY / ACCESS Newswire / May 27, 2025 / If you suffered a loss on your Napco Security Technologies, Inc. (NASDAQ:NSSC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/napco-security-technologies-inc-lawsuit-submission-form-2?prid=150407&wire=1&utm_campaign=24 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / May 27, 2025 / If you suffered a loss on your Ibotta, Inc. (NYSE:IBTA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/ibotta-lawsuit-submission-form?prid=150409&wire=1&utm_campaign=18 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / May 27, 2025 / If you suffered a loss on your UnitedHealth Group Incorporated (NYSE:UNH) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/unitedhealth-group-incorporated-lawsuit-submission-form?prid=150408&wire=1&utm_campaign=29 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / May 27, 2025 / If you suffered a loss on your Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/iovance-biotherapeutics-inc-lawsuit-submission-form?prid=150406&wire=1&utm_campaign=25 or contact Joseph E. Levi, Esq.

SAN FRANCISCO, May 27, 2025 (GLOBE NEWSWIRE) -- On May 21, 2025, investors in UroGen Pharma Ltd. (NASDAQ: URGN) saw the price of their shares crash 44% after the company announced that the FDA's Oncologic Drugs Advisory Committee (“ODAC”) voted against the risk/benefit profile of UroGen's UGN-102, a therapy intended to treat patients with low-grade, intermediate-risk non-muscle invasive bladder cancer (“LG-IR-NMIBC”) for which no drugs are currently FDA-approved.

Meta is dividing its AI department into two new teams, according to a report from Axios. Now, the company's AI personnel will be assigned to an AI products team, or an AGI Foundations unit.

Moody's U.S. credit downgrade has pushed long-term Treasury yields higher, making Vanguard Extended Duration Treasury Index Fund ETF Shares's return/risk profile unusually attractive versus equities. EDV offers a compelling package among many peer ETFs such as low fees and strong liquidity. With equity valuations stretched and geopolitical risks elevated, EDV provides valuable diversification and acts as an effective hedge in volatile markets.

SAN FRANCISCO, May 27, 2025 (GLOBE NEWSWIRE) -- On May 15, 2025, investors in Coinbase Global, Inc. (NASDAQ: COIN) saw the price of their shares slide about 7% after the company announced that it experienced a material cybersecurity incident, raising questions about the adequacy of its internal controls and disclosure processes.

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of New Fortress Energy Inc. (“New Fortress” or the “Company”) (NASDAQ: NFE) investors concerning the Company's possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON NEW FORTRESS ENERGY INC. (NFE), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. What Happ.

Paypal's price to value strategy with Braintree is helping drive modest transaction margin growth. But many other key metrics such as payment volumes, TPVs and active accounts growth are all posting disappointing figures. PYPL's valuation discount to peers is narrower than usual, which I believe is unjustified given weak fundamental performance.

Retailer Foot Locker Inc (NYSE:FL) will announce its latest quarterly results before the open Thursday, May 29.

Great Lakes Dredge & Dock posted 300%+ net income growth in 2024, driven by strong execution, margin expansion, and a $1B+ high-margin backlog. Valuation remains compelling at 10.6x P/E and 8.0x EV/EBITDA, making GLDD a clear late-cycle opportunity as earnings continue to accelerate. Backlog is dominated (95%) by capital and coastal protection projects, positioning GLDD for higher margins, continued profitability and steady cash flows.

Nvidia's (NVDA) sales growth has slowed, down sharply from over 250% a year ago. Yahoo Finance Markets and Data Editor Jared Blikre, who also hosts Yahoo Finance's Stocks In Translation podcast, breaks down what Nvidia's cooling momentum could mean for the broader artificial intelligence (AI) trade ahead of the company's earnings.

B of A Securities analyst Wamsi Mohan revised full-year estimates for Pure Storage, Inc. PSTG ahead of its earnings release on May 28.

CFRA's Angelo Zino believes "all eyes" will be on Nvidia's (NVDA) revenue and guidance in Wednesday's earnings. Data center and Blackwell revenue are crucial for the company, according to Angelo, as the A.I.

NEW YORK, NY / ACCESS Newswire / May 27, 2025 / If you suffered a loss on your Compass Group Diversified Holdings, LLC (NYSE:CODI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/compass-diversified-lawsuit-submission-form?prid=150405&wire=1&utm_campaign=21 or contact Joseph E. Levi, Esq.

SAN FRANCISCO, May 27, 2025 (GLOBE NEWSWIRE) -- A securities class action lawsuit has been filed against Compass Diversified (NYSE: CODI) and certain of its executives after the company disclosed that it would restate its 2024 financial statements due to unrecorded financing arrangements and “irregularities” within its Lugano business unit. The suit, styled Matthews v. Compass Diversified Holdings, LLC, et al., No. 8:25-cv-00981 (C.D. Cal.), seeks to represent investors who purchased Compass Diversified securities between May 1, 2024 and May 7, 2025.

Grocery chain Sprouts Farmers Market Inc (NASDAQ:SFM) has been chopping higher over the past year, doubling since last May and up 30% in 2025.

SAN FRANCISCO, May 27, 2025 (GLOBE NEWSWIRE) -- Biotechnology firm Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) is facing a securities class action lawsuit in the Northern District of California, alleging that the company misled investors about its growth potential and ability to capitalize on demand for its cancer treatments. The case, Farberov v. Iovance Biotherapeutics, Inc., et al., centers on statements made between May 9, 2024, and May 8, 2025, a period that includes an expansion from the initial August 2024 start date.